The Child Network for Parents to Track Their Child's Mood and Behavior

Robert M. Post, Michael Rowe, Dana Kaplan, Robert L Findling

Research output: Contribution to journalArticle

Abstract

Introduction: A wide range of psychiatric disorders are common in young children, especially in those at high risk because of a parent with a unipolar or bipolar mood disorder in the United States. Yet in part because most children are seen in primary care, these illnesses are often not recognized or treated in a timely fashion. To begin to address this problem, we started the Child Network. Methods: The Child Network is for parents of children age 2-12 with mood or behavioral symptoms or at high risk for them. The parents rate the severity of symptoms of depression, anxiety, attention-deficit/hyperactivity disorder (ADHD), oppositional behavior, and mania on a once a week basis on a secure website under a Johns Hopkins Intramural Review Board (IRB)-approved protocol. These ratings can then be printed out along with any treatments given to aide in visualization of symptom course. A demographics form, which includes diagnoses given to the child in the community, and a symptom checklist are filled out upon Network entry. We report on the retrospective diagnoses and prospective treatment of the first 65 parents to join the Network. Results: The most common diagnoses were anxiety disorders and ADHD followed by disruptive behavioral disorders and bipolar spectrum disorders. Prospective ratings of two or more consecutive weeks of moderate to severe rating in any of the five symptom domains paralleled these diagnoses given in the community. Atypical antipsychotics, anticonvulsant mood stabilizers, and medications for ADHD were among the most widely used drugs. An illustrated example of symptom course is presented. Discussion: Many children continued to show substantial symptom severity despite treatment with an average of 2.2 medications. The Child Network provides a useful longitudinal approach to visualize the course of symptoms, which should help lead to earlier and more effective treatment.

Original languageEnglish (US)
Pages (from-to)840-843
Number of pages4
JournalJournal of Child and Adolescent Psychopharmacology
Volume27
Issue number9
DOIs
StatePublished - Nov 1 2017

Fingerprint

Child Behavior
Parents
Attention Deficit Disorder with Hyperactivity
Bipolar Disorder
Behavioral Symptoms
Therapeutics
Anxiety Disorders
Checklist
Mood Disorders
Anticonvulsants
Antipsychotic Agents
Psychiatry
Primary Health Care
Anxiety
Demography
Depression
Pharmaceutical Preparations

Keywords

  • ADHD
  • anxiety
  • childhood onset bipolar disorder
  • depression
  • pharmacological treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

The Child Network for Parents to Track Their Child's Mood and Behavior. / Post, Robert M.; Rowe, Michael; Kaplan, Dana; Findling, Robert L.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 27, No. 9, 01.11.2017, p. 840-843.

Research output: Contribution to journalArticle

@article{fe020e53d00543d4b89c420bec28fac0,
title = "The Child Network for Parents to Track Their Child's Mood and Behavior",
abstract = "Introduction: A wide range of psychiatric disorders are common in young children, especially in those at high risk because of a parent with a unipolar or bipolar mood disorder in the United States. Yet in part because most children are seen in primary care, these illnesses are often not recognized or treated in a timely fashion. To begin to address this problem, we started the Child Network. Methods: The Child Network is for parents of children age 2-12 with mood or behavioral symptoms or at high risk for them. The parents rate the severity of symptoms of depression, anxiety, attention-deficit/hyperactivity disorder (ADHD), oppositional behavior, and mania on a once a week basis on a secure website under a Johns Hopkins Intramural Review Board (IRB)-approved protocol. These ratings can then be printed out along with any treatments given to aide in visualization of symptom course. A demographics form, which includes diagnoses given to the child in the community, and a symptom checklist are filled out upon Network entry. We report on the retrospective diagnoses and prospective treatment of the first 65 parents to join the Network. Results: The most common diagnoses were anxiety disorders and ADHD followed by disruptive behavioral disorders and bipolar spectrum disorders. Prospective ratings of two or more consecutive weeks of moderate to severe rating in any of the five symptom domains paralleled these diagnoses given in the community. Atypical antipsychotics, anticonvulsant mood stabilizers, and medications for ADHD were among the most widely used drugs. An illustrated example of symptom course is presented. Discussion: Many children continued to show substantial symptom severity despite treatment with an average of 2.2 medications. The Child Network provides a useful longitudinal approach to visualize the course of symptoms, which should help lead to earlier and more effective treatment.",
keywords = "ADHD, anxiety, childhood onset bipolar disorder, depression, pharmacological treatment",
author = "Post, {Robert M.} and Michael Rowe and Dana Kaplan and Findling, {Robert L}",
year = "2017",
month = "11",
day = "1",
doi = "10.1089/cap.2017.0002",
language = "English (US)",
volume = "27",
pages = "840--843",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - The Child Network for Parents to Track Their Child's Mood and Behavior

AU - Post, Robert M.

AU - Rowe, Michael

AU - Kaplan, Dana

AU - Findling, Robert L

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Introduction: A wide range of psychiatric disorders are common in young children, especially in those at high risk because of a parent with a unipolar or bipolar mood disorder in the United States. Yet in part because most children are seen in primary care, these illnesses are often not recognized or treated in a timely fashion. To begin to address this problem, we started the Child Network. Methods: The Child Network is for parents of children age 2-12 with mood or behavioral symptoms or at high risk for them. The parents rate the severity of symptoms of depression, anxiety, attention-deficit/hyperactivity disorder (ADHD), oppositional behavior, and mania on a once a week basis on a secure website under a Johns Hopkins Intramural Review Board (IRB)-approved protocol. These ratings can then be printed out along with any treatments given to aide in visualization of symptom course. A demographics form, which includes diagnoses given to the child in the community, and a symptom checklist are filled out upon Network entry. We report on the retrospective diagnoses and prospective treatment of the first 65 parents to join the Network. Results: The most common diagnoses were anxiety disorders and ADHD followed by disruptive behavioral disorders and bipolar spectrum disorders. Prospective ratings of two or more consecutive weeks of moderate to severe rating in any of the five symptom domains paralleled these diagnoses given in the community. Atypical antipsychotics, anticonvulsant mood stabilizers, and medications for ADHD were among the most widely used drugs. An illustrated example of symptom course is presented. Discussion: Many children continued to show substantial symptom severity despite treatment with an average of 2.2 medications. The Child Network provides a useful longitudinal approach to visualize the course of symptoms, which should help lead to earlier and more effective treatment.

AB - Introduction: A wide range of psychiatric disorders are common in young children, especially in those at high risk because of a parent with a unipolar or bipolar mood disorder in the United States. Yet in part because most children are seen in primary care, these illnesses are often not recognized or treated in a timely fashion. To begin to address this problem, we started the Child Network. Methods: The Child Network is for parents of children age 2-12 with mood or behavioral symptoms or at high risk for them. The parents rate the severity of symptoms of depression, anxiety, attention-deficit/hyperactivity disorder (ADHD), oppositional behavior, and mania on a once a week basis on a secure website under a Johns Hopkins Intramural Review Board (IRB)-approved protocol. These ratings can then be printed out along with any treatments given to aide in visualization of symptom course. A demographics form, which includes diagnoses given to the child in the community, and a symptom checklist are filled out upon Network entry. We report on the retrospective diagnoses and prospective treatment of the first 65 parents to join the Network. Results: The most common diagnoses were anxiety disorders and ADHD followed by disruptive behavioral disorders and bipolar spectrum disorders. Prospective ratings of two or more consecutive weeks of moderate to severe rating in any of the five symptom domains paralleled these diagnoses given in the community. Atypical antipsychotics, anticonvulsant mood stabilizers, and medications for ADHD were among the most widely used drugs. An illustrated example of symptom course is presented. Discussion: Many children continued to show substantial symptom severity despite treatment with an average of 2.2 medications. The Child Network provides a useful longitudinal approach to visualize the course of symptoms, which should help lead to earlier and more effective treatment.

KW - ADHD

KW - anxiety

KW - childhood onset bipolar disorder

KW - depression

KW - pharmacological treatment

UR - http://www.scopus.com/inward/record.url?scp=85033781067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033781067&partnerID=8YFLogxK

U2 - 10.1089/cap.2017.0002

DO - 10.1089/cap.2017.0002

M3 - Article

C2 - 28441041

AN - SCOPUS:85033781067

VL - 27

SP - 840

EP - 843

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 9

ER -